Evaluating a B2B cannabis supplier requires assessing licence standing, quality documentation, batch consistency, and export capability, not just price and availability. For licensed importers, pharmacy distributors, and international procurement teams, choosing the wrong supplier means regulatory exposure, shipment failures, and customer complaints that are difficult to reverse once a supply relationship is live.
The stakes are higher in international cannabis procurement than in most commodity categories. A Health Canada Licensed Producer supplying Germany must maintain EU-GMP alignment. One supplying Australia must meet TGO 93. One supplying Israel must satisfy IMC-GMP. A supplier that passes your initial review but fails a destination-market quality check costs your organisation far more than a rigorous upfront evaluation would have.
This checklist covers every category B2B buyers should assess when qualifying a cannabis supplier: licence and compliance status, quality systems, COA standards, batch consistency, export history, and supply reliability.
Licence and compliance verification
Licence verification is the first step in any cannabis supplier evaluation, and it should be non-negotiable. A supplier's Health Canada Standard Cultivation Licence is publicly searchable on the Health Canada licenced producer registry. Verify it before any commercial discussion proceeds.
Check the following directly on the registry:
- Licence class: Standard Cultivation (required for export) vs Micro Cultivation (export limitations apply)
- Licence expiry date and whether a renewal application is pending
- Authorised activities: cultivation, processing, sale, and export must all be listed
- Any conditions or restrictions noted on the licence
For suppliers targeting European markets, also request documentation of their EU-GMP certification status or their alignment with the Mutual Recognition Agreement between Canada and the EU. EU-GMP certification is issued by a European regulatory authority, not Health Canada, so ask for the certificate directly, not just a claim.
How to read a GPP audit summary
The most recent GPP audit report or summary is your best window into how a supplier actually runs its facility. Look for: the date of the most recent audit, whether any critical or major observations were raised, and what corrective actions were taken. An LP with a clean audit history and documented corrective action plans for minor observations is more credible than one that claims a perfect record but cannot produce paperwork. Ask for the last two audit cycles, not just the most recent one.
Quality documentation and COA standards
Quality documentation is where most cannabis supplier evaluations succeed or fail. The Certificate of Analysis is the primary product-level quality document, and its completeness, laboratory accreditation, and consistency across batches tell you most of what you need to know about a supplier's operational standards.
Request COAs from at least three consecutive batches of the cultivar you plan to source. Assess them for:
- Laboratory accreditation: issuing lab must hold ISO/IEC 17025 accreditation. Non-accredited results are not acceptable for international procurement
- Potency panel completeness: THC, CBD, and calculated Total THC at minimum. CBG, CBN, and THCV are increasingly requested
- Microbial testing: TAMC, TYMC, and specified pathogens including Salmonella, E. coli, Pseudomonas aeruginosa
- Heavy metals, pesticide residues, and aflatoxins
- Moisture content and water activity where applicable
For a detailed breakdown of how to read and evaluate a COA, see our B2B Cannabis COA guide. Pay particular attention to whether the COA results are presented in units matching your destination market's standard. A COA that does not map cleanly to EU-GMP, TGO 93, or IMC-GMP requirements creates compliance work for your team before every shipment.
Assessing batch-to-batch consistency
Potency variance is the most common quality complaint in ongoing cannabis supply relationships. Calculate the THC variance across the three COAs you requested. Variance above 15% on Total THC across the same cultivar and the same grow cycle is a warning sign. Suppliers running tight indoor operations with consistent environmental controls typically show tighter variance. Ask what explains any outlier batch before discounting it.
Export capability and track record
A supplier's export capability is distinct from their domestic licence standing. Not every Health Canada Licensed Producer has successfully completed an international shipment, and first-shipment logistics carry more risk than ongoing supply. Assess export capability directly during qualification.
Ask for the following:
- Countries shipped to and approximate shipment dates (a reference list, not full commercial details)
- Whether the supplier holds an export authorisation under the Cannabis Act for your target market
- Their Health Canada export permit turnaround time (established suppliers with a permit history typically see four to six weeks)
- Freight forwarder partners with narcotics handling experience in your destination country
- Documentation turnaround for phytosanitary certificates, COAs, and batch records post-production
A supplier who has completed multiple shipments to your target market has already resolved the documentation gaps that delay first shipments. That operational experience has real commercial value, particularly for buyers with quarterly supply commitments.
Supply reliability and production capacity
Ask for the supplier's annual production capacity and their current committed volume. A supplier at 90% of capacity with three long-term customers has limited buffer for a new relationship. Understand their harvest cycle and how much advance notice they need to reserve batch allocation. For international buyers on fixed import permit timelines, a supplier who cannot provide eight to twelve weeks of production visibility is a supply risk regardless of their quality credentials.
Facility audit and final qualification
A facility audit, whether in-person or documented, is the final stage of supplier qualification for high-volume or long-term B2B cannabis relationships. Some importers complete a paper audit first (reviewing facility documentation, SOPs, and quality records) and reserve physical audits for suppliers they intend to contract with. Either approach is valid. What matters is that an audit happens before a multi-year supply agreement is signed.
During a facility audit, assess:
- Environmental controls: HVAC, humidity, CO2, and lighting records across recent grow cycles
- Pest management logs: chemical inputs, application records, and harvest hold periods
- Post-harvest handling: drying environment, trimming workflow (hand-trim vs machine), and curing controls
- Batch traceability: can the supplier trace a finished product unit back to the individual plant lot and grow cycle?
- SOP documentation: are SOPs current, version-controlled, and accessible to production staff?
AlphaLeaf is a Health Canada Licensed Producer based in Montreal with a controlled indoor facility, full batch traceability, hand-trimmed production, and ISO/IEC 17025-accredited testing on every batch. Our Ice Cream Cake cultivar (30.3% THC, Wedding Cake x Gelato cross, large-bud format above 5cm) is available for international procurement. B2B buyers can request documentation packages and schedule qualification calls through our contact page.
Red flags that should end a qualification process
Some findings during supplier qualification should stop the process outright. If a supplier cannot produce a verifiable Health Canada licence, provides COAs from non-accredited laboratories, shows potency variance above 15% without explanation, cannot produce a GPP audit summary, or declines to discuss export history in any detail, those are signals that the relationship will create compliance problems downstream. The cost of disqualifying a supplier during evaluation is always lower than the cost of managing a supply failure after a contract is signed.
Frequently Asked Questions
What licences should a Canadian cannabis supplier hold to export internationally?
A Canadian LP must hold a Standard Cultivation Licence and an export authorisation under the Cannabis Act. For European markets, EU-GMP certification or documented Mutual Recognition Agreement alignment is typically required. Verify licence status directly on Health Canada's public registry before proceeding.
What should a cannabis COA include for international B2B procurement?
A compliant COA must include cannabinoid potency, microbial results, heavy metals, pesticide residues, aflatoxins, and moisture content, issued by an ISO/IEC 17025-accredited laboratory. Results should be in units matching the destination market's regulatory standard.
How many COAs should I request before approving a cannabis supplier?
Request COAs from a minimum of three consecutive batches of the same cultivar. This establishes a baseline for potency variance, microbial consistency, and testing panel completeness. A single COA is not sufficient to assess supply reliability.
What does a cannabis supplier's GPP audit report tell me?
A GPP audit report reveals how the supplier's facility, processes, and quality systems measure against Canadian regulatory standards. Request the last two audit cycles and any corrective action plans, which show how the LP responds to findings over time.
What red flags should disqualify a cannabis supplier during procurement?
Disqualifying red flags include: an unverifiable Health Canada licence, COAs from non-ISO/IEC 17025 accredited labs, potency variance above 15% without explanation, no GPP audit documentation, no export history for your target market, and refusal to support a facility audit. Any one of these warrants stopping the evaluation.
